儿童麻疹疫苗基础免疫应答者与无应答者的加强免疫应答动态*

周晓钰 ,  汪千力 ,  杨娟 ,  廖巧红 ,  张娟娟 ,  赵思泓 ,  周嘉欣 ,  赵泽耀 ,  梁玉霞 ,  罗俊藤 ,  蔡京廷 ,  吴研鹏 ,  余宏杰 ,  王微

中国卫生统计 ›› 2026, Vol. 43 ›› Issue (5) : 642 -646.

PDF (1677KB)
中国卫生统计 ›› 2026, Vol. 43 ›› Issue (5) : 642 -646. DOI: 10.11783/j.issn.1002-3674.2026.05.001
论著

儿童麻疹疫苗基础免疫应答者与无应答者的加强免疫应答动态*

作者信息 +

Vaccine-induced Immune Response and Dynamics in Responders and Non- responders to Primary Vaccination against Measles

Author information +
文章历史 +
PDF (1716K)

摘要

目的 评估儿童常规两剂次麻疹疫苗(measles-containing vaccine,MCV)接种后,第一剂次疫苗(MCV1, 即基础免疫)应答者与无应答者的免疫动态变化差异及影响因素。方法 基于2013—2021 年湖南省安化县母婴/儿童纵 向队列,采用酶联免疫吸附法测定两队列儿童血清样本中的麻疹IgG 抗体浓度,并分析MCV1 应答者和无应答者在其第 二剂次MCV 接种(MCV2,即加强免疫)后的抗体浓度、衰减速率、转阴风险及影响因素。结果 在本研究纳入的452 名 MCV1 应答者(91.5%)与42 名无应答者(8.5%)中,MCV1 无应答者的MCV1 诱导抗体浓度显著低于应答者(3.0 vs. 7.7 log mIU/mL)。尽管加强免疫后,两者的抗体总浓度呈相当水平,但其抗体衰减速度(MCV1 应答者 vs 无应答者: 0.008 vs. 0.004 log mIU/mL/月,P< 0.001)和免疫保护持久性(7.3年vs. 4.3年)存在显著差异。多因素分析提示,两者MCV2接种前 的预存抗体浓度是其MCV2 接种后抗体衰减速率的唯一影响因素(β = -3.75e-04,P= 0.004),抗体浓度越高、衰减越慢。 结论 当前我国两剂次MCV 接种程序对MCV1应答/无应答者提供的免疫保护均不足,亟待优化针对该人群的强化免疫 策略,加速推进我国麻疹消除目标。

Abstract

Objective To evaluate the differences in the dynamics of vaccine-induced immunity and potential influencing factors after receiving 2 doses of measles-containing vaccine (MCV) between non-responders and responders to primary vaccination against measles (MCV1).Methods Serum samples were collected from two prospective cohorts between 2013 and 2021 in Anhua County, Hunan Province, and measles-specific IgG antibody concentrations were tested using enzyme linked immunosorbent assay. The antibody concentrations, decay rates, risks of seroconversion and potential influencing factors of MCV1 responders and non-responders after MCV2 vaccination were analysed using statistical models.Results A total of 452 MCV1 responders (91. 5%) and 42 non-responders (8. 5%) were enrolled. The GMC of MCV1-induced antibodies among MCV1 non-responders was lower than that of MCV1 responders (3. 0 vs. 7. 7 log mIU/mL). Although antibody concentrations were comparable between the two groups following the second dose of MCV (MCV2), the significant differences of decline (0. 008 versus 0. 004 log mIU/mL per month, P < 0. 001) and persistence (7. 3 years vs. 4. 3 years) in immunity were observed. Furthermore, multivariate analysis revealed that the pre-existing antibody level prior to MCV2 vaccination was the only factor associated with the antibody decay rate after vaccination (β = -3. 75e-04, P = 0. 004), suggesting that higher pre-existing antibody levels correlate with faster waning of immunity.Conclusion The insufficient immunity conferred by two doses of MCV in MCV1 non-responders indicates the need for optimization of immunization strategy to accelerate the measles elimination process in China.

关键词

麻疹疫苗 / 抗体变化 / 无应答者 / 免疫动态建模

Key words

Measles-containing vaccine / Antibody dynamics / Non-responder / Immune dynamic modeling

引用本文

引用格式 ▾
周晓钰,汪千力,杨娟,廖巧红,张娟娟,赵思泓,周嘉欣,赵泽耀,梁玉霞,罗俊藤,蔡京廷,吴研鹏,余宏杰,王微. 儿童麻疹疫苗基础免疫应答者与无应答者的加强免疫应答动态*[J]. 中国卫生统计, 2026, 43(5): 642-646 DOI:10.11783/j.issn.1002-3674.2026.05.001

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Minta AA, Ferrari M, Antoni S, et al. Progress Toward Measles Elimination — Worldwide, 2000—2022[J].MMWR Morb Mortal Wkly Rep, 2023, 72(46): 1262-1268 .

[2]

Makarenko C, San Pedro A, Paiva NS, et al. Measles resurgence in Brazil: analysis of the 2019 epidemic in the state of São Paulo[J].Rev Saude Publica, 2022, 56: 50 .

[3]

Böröcz K, Markovics Á, Csizmadia Z, et al. Imported Infections Versus Herd Immunity Gaps; A Didactic Demonstration of Com— partment Models Through the Example of a Minor Measles Out— break in Hungary[J].South Eastern European Medical Journal, 2021, 5(1): 1-16.

[4]

Funk S, Knapp JK, Lebo E, et al. Combining serological and con— tact data to derive target immunity levels for achieving and main— taining measles elimination[J].BMC Med, 2019, 17(1): 180 .

[5]

World Health Organization. Measles cases surge worldwide, infect— ing 10. 3 million people in 2023[EB/OL]. (2024—11—14) [2025—01— 10].https://www. who. int/news/item/14—11—2024—measles—cases— surge—worldwide——infecting—10. 3—million—people—in—2023.

[6]

Ma C, Rodewald L, Hao L, et al. Progress Toward Measles Elimi— nation — China, January 2013—June 2019[J].MMWR Morb Mortal Wkly Rep, 2019, 68(48): 1112-1116 .

[7]

Musa N, Ghoniem A, Hsu CH, et al. Progress Toward Measles Elimination — World Health Organization Eastern Mediterranean Region, 2019—2022[J].MMWR Morb Mortal Wkly Rep, 2024, 73 (7): 139-144.

[8]

中国疾病预防控制中心. 重点传染病和突发公共卫生事件风险 评估报告[EB/OL]. [2025—09—24].https://www. chinacdc. cn/jksj/ jksj02/.

[9]

Wang Q, Wang W, Winter AK, et al. Long—term measles antibody profiles following different vaccine schedules in China, a longitudi— nal study[J].Nat Commun, 2023, 14(1): 1746.

[10]

Wang W, O'Driscoll M, Wang Q, et al. Dynamics of measles immunity from birth and following vaccination[J].Nat Microbiol, 2024, 9(7): 1676-1685.

[11]

Nic Lochlainn LM, de Gier B, van der Maas N, et al. Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta—analysis[J].Lancet Infect Dis, 2019, 19(11): 1246-1254.

[12]

Li Volti S, Giammanco—Bilancia G, Grassi M, et al. Duration of the immune response to MMR vaccine in children of two age—different groups[J].Eur J Epidemiol, 1993, 9(3): 311-314.

[13]

Hr TN, Barlıanto W, Wıyasa IWA, et al. Analysis of specific anti— body and cellular immune response to first—dose measles vaccine Edmonston—Zagreb in 9—month—old infants[J].Allergol Immuno— pathol (Madr), 2021, 49(3): 193-201.

[14]

LeBaron CW, Beeler J, Sullivan BJ, et al. Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment[J].Arch Pediatr Adolesc Med, 2007, 161(3): 294-301 .

[15]

Techasena W, Sriprasert P, Pattamadilok S, et al. Measles antibody in mothers and infants 0—2 years and response to measles vaccine at the age of 9 and 18 months[J].J Med Assoc Thai, 2007, 90(1): 106-112.

[16]

Wei X, Yang J, Gao L, et al. The transfer and decay of maternal antibodies against enterovirus A71, and dynamics of antibodies due to later natural infections in Chinese infants: a longitudinal, paired mother—neonate cohort study[J].Lancet Infect Dis, 2021, 21(3): 418-426.

[17]

Zhou J, Zhou Y, Luo K, et al. The transfer of maternal antibodies and dynamics of maternal and natural infection—induced antibodies against coxsackievirus A16 in Chinese children 0—13 years of age: a longitudinal cohort study[J].BMC Med, 2022, 20(1): 436.

[18]

Argüelles MH, Orellana ML, Castello AA, et al. Measles virus— specific antibody levels in individuals in Argentina who received a one—dose vaccine[J].J Clin Microbiol, 2006, 44(8): 2733-2738.

[19]

Gans HA, Arvin AM, Galinus J, et al. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months[J].JAMA, 1998, 280(6): 527-532.

[20]

Brinkman ID, de Wit J, Smits GP, et al. Early Measles Vaccination During an Outbreak in the Netherlands: Short—Term and Long—Term Decreases in Antibody Responses Among Children Vaccinated Before 12 Months of Age[J].J Infect Dis, 2019, 220(4): 594-602.

[21]

Mok DZL, Chan KR. The Effects of Pre—Existing Antibodies on Live—Attenuated Viral Vaccines[J].Viruses, 2020, 12(5): 12050520.

[22]

Amanna IJ, Slifka MK. Mechanisms that determine plasma cell lifespan and the duration of humoral immunity[J].Immunol Rev, 2010, 236(1): 125-138.

[23]

Shang L, Zhou X. Spatially aware dimension reduction for spatial transcriptomics[J].Nature Communications, 2022, 13(1): 7203.

[24]

Korsunsky I, Millard N, Fan J, et al. Fast, sensitive and accurate integration of single—cell data with Harmony[J].Nature Methods, 2019, 16(12): 1289-1296.

[25]

Kodinariya TM, Makwana PR. Review on determining number of Cluster in K—Means Clustering[J].International Journal, 2013, 1(6): 90-95.

[26]

Li J, Ding Y, Li A. Identification of COL1A1 and COL1A2 as can— didate prognostic factors in gastric cancer[J].World Journal of Sur— gical Oncology, 2016, 14: 1-5.

[27]

Zhang G, Li T, Tan G, et al. Identity of MMP1 and its effects on tumor progression in head and neck squamous cell carcinoma[J].Cancer Medicine, 2022, 11(12): 2516-2530.

[28]

Yu Y, Liu D, Liu Z, et al. The inhibitory effects of COL1A2 on colorectal cancer cell proliferation, migration, and invasion[J]. Jour— nal of Cancer,2018, 9(16): 2953.

[29]

Hayashi M, Nomoto S, Hishida M, et al. Identification of the colla— gen type 1 alpha 1 gene (COL1A1) as a candidate survival—related factor associated with hepatocellular carcinoma[J].BMC Cancer, 2014, 14: 1-10.

[30]

Wang Z, Wang Q, Wang Q, et al. Prognostic significance of CD24 and CD44 in breast cancer: a meta—analysis[J].The International Journal of Biological Markers, 2017, 32(1): 75-82.

[31]

Barkal AA, Brewer RE, Markovic M, et al. CD24 signalling through macrophage Siglec—10 is a target for cancer immunotherapy [J].Nature, 2019, 572(7769): 392-396.

[32]

Chang TM, Chiang YC, Lee CW, et al. CXCL14 promotes metasta— sis of non—small cell lung cancer through ACKR2—depended signal— ing pathway[J].International Journal of Biological Sciences, 2023, 19(5): 1455.

[33]

Parikh A, Shin JH, Faquin W, et al. Malignant cell—specific CXCL14 promotes tumor lymphocyte infiltration in oral cavity squamous cell carcinoma[J].Journal for ImmunoTherapy of Can— cer, 2020, 8(2):e001048.

[34]

Lee JU, Kim WH, Lee HS, et al. Quantitative and specific detection of exosomal miRNAs for accurate diagnosis of breast cancer using a surface—enhanced Raman scattering sensor based on plasmonic head— flocked gold nanopillars[J].Small, 2019, 15(17): 1804968.

[35]

Bourguignon LYW. Hyaluronan—mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression[C].Seminars in Cancer Biology. Academic Press, 2008, 18(4): 251-259.

[36]

Long Y, Ang KS, Li M, et al. Spatially informed clustering, integra— tion, and deconvolution of spatial transcriptomics with GraphST[J].Nature Communications, 2023, 14(1): 1155.

[37]

Ma Y, Zhou X. Accurate and efficient integrative reference— informed spatial domain detection for spatial transcriptomics[J].Nature Methods, 2024, 21(7): 1231-1244.

[38]

Chen Y, Zhen C, Mo Y, et al. Multiscale Dissection of Spatial Het— erogeneity by Integrating Multi—Slice Spatial and Single—Cell Tran— scriptomics[J].Advanced Science, 2025,12(15): e 2413124.

基金资助

上海市市级科技重大专项(ZD2021CY001)

国家自然科学基金(82130093)

国家自然科学基金(92369118)

国家自然科学基金(82304202)

国家自然科学基金(82304205)

AI Summary AI Mindmap
PDF (1677KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉